Kim, E.-y.; Lee, B.; Kwon, S.; Corson, T.W.; Seo, S.-Y.; Lee, K.
Mouse Pharmacokinetics and In Vitro Metabolism of SH-11037 and SH-11008, Synthetic Homoisoflavonoids for Retinal Neovascularization. Pharmaceutics 2022, 14, 2270.
https://doi.org/10.3390/pharmaceutics14112270
AMA Style
Kim E-y, Lee B, Kwon S, Corson TW, Seo S-Y, Lee K.
Mouse Pharmacokinetics and In Vitro Metabolism of SH-11037 and SH-11008, Synthetic Homoisoflavonoids for Retinal Neovascularization. Pharmaceutics. 2022; 14(11):2270.
https://doi.org/10.3390/pharmaceutics14112270
Chicago/Turabian Style
Kim, Eun-yeong, Bit Lee, Sangil Kwon, Timothy W. Corson, Seung-Yong Seo, and Kiho Lee.
2022. "Mouse Pharmacokinetics and In Vitro Metabolism of SH-11037 and SH-11008, Synthetic Homoisoflavonoids for Retinal Neovascularization" Pharmaceutics 14, no. 11: 2270.
https://doi.org/10.3390/pharmaceutics14112270
APA Style
Kim, E. -y., Lee, B., Kwon, S., Corson, T. W., Seo, S. -Y., & Lee, K.
(2022). Mouse Pharmacokinetics and In Vitro Metabolism of SH-11037 and SH-11008, Synthetic Homoisoflavonoids for Retinal Neovascularization. Pharmaceutics, 14(11), 2270.
https://doi.org/10.3390/pharmaceutics14112270